A landmark longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
Robotic Phlebotomy Study Signals Automation Shift for Clinical Labs
A newly published multicenter clinical study marks a pivotal moment for clinical laboratories, signaling a potential paradigm shift in how…
Read More
Unconventional Discovery of Lithium in Appalachian Basin Pyrite Signals a Potential Shift in Global Mineral Sourcing for the Green Energy Transition
The global race to secure a steady supply of critical minerals has taken an unexpected turn following a groundbreaking discovery…
Read More
NYC Health + Hospitals CEO Signals Willingness to Replace Radiologists with AI
The pronouncement from the head of New York City’s vast public health system signals a potentially transformative shift in how…
Read More
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
A groundbreaking longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
Robotic Phlebotomy Study Signals Automation Shift for Clinical Labs
A newly published multicenter clinical study is poised to fundamentally reshape the landscape of diagnostic medicine, signaling a significant shift…
Read More
NYC Health + Hospitals CEO Signals Willingness to Replace Radiologists with AI
The pronouncement by Mitchell H. Katz, MD, President and CEO of NYC Health + Hospitals, the largest public healthcare system…
Read More
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
A groundbreaking new longitudinal study, published April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
NYC Health + Hospitals CEO Signals Willingness to Replace Radiologists with AI
The pronouncement by Mitchell H. Katz, MD, president and CEO of NYC Health + Hospitals, the largest public healthcare system…
Read More
MSD’s $6.7 Billion Acquisition of Terns Pharmaceuticals Signals a Bold Strategic Pivot in Oncology to Secure Future Growth
On March 25, Merck & Co. (MSD) announced a significant strategic move, acquiring Terns Pharmaceuticals for an estimated $6.7 billion…
Read More
